In addition, in cancer cells, there was a strong tendency of co-occurrence between high LGALS3BP, high USF1, high USF2, and high TGF-β1 expression (p < 0.001) or low LGALS3BP, low USF1, low USF2, and low TGF-β1 expression (p < 0.001) (Fig. 5F). This evidence concerns the gene LGALS3BP and cancer.